Revealing the influence of electron beam melted Ti-6Al-4V scaffolds on osteogenesis of human bone marrow-derived mesenchymal stromal cells.


Journal

Journal of materials science. Materials in medicine
ISSN: 1573-4838
Titre abrégé: J Mater Sci Mater Med
Pays: United States
ID NLM: 9013087

Informations de publication

Date de publication:
18 Aug 2021
Historique:
received: 19 04 2021
accepted: 23 07 2021
entrez: 18 8 2021
pubmed: 19 8 2021
medline: 19 1 2022
Statut: epublish

Résumé

Porous Titanium-6Aluminum-4Vanadium scaffolds made by electron beam-based additive manufacturing (AM) have emerged as state-of-the-art implant devices. However, there is still limited knowledge on how they influence the osteogenic differentiation of bone marrow-derived mesenchymal stromal cells (BMSCs). In this study, BMSCs are cultured on such porous scaffolds to determine how the scaffolds influence the osteogenic differentiation of the cells. The scaffolds are biocompatible, as revealed by the increasing cell viability. Cells are evenly distributed on the scaffolds after 3 days of culturing followed by an increase in bone matrix development after 21 days of culturing. qPCR analysis provides insight into the cells' osteogenic differentiation, where RUNX2 expression indicate the onset of differentiation towards osteoblasts. The COL1A1 expression suggests that the differentiated osteoblasts can produce the osteoid. Alkaline phosphatase staining indicates an onset of mineralization at day 7 in OM. The even deposits of calcium at day 21 further supports a successful bone mineralization. This work shines light on the interplay between AM Ti64 scaffolds and bone growth, which may ultimately lead to a new way of creating long lasting bone implants with fast recovery times.

Identifiants

pubmed: 34406475
doi: 10.1007/s10856-021-06572-0
pii: 10.1007/s10856-021-06572-0
pmc: PMC8373740
doi:

Substances chimiques

Alloys 0
Biocompatible Materials 0
Bone Substitutes 0
Collagen Type I, alpha 1 Chain 0
Core Binding Factor Alpha 1 Subunit 0
RUNX2 protein, human 0
titanium alloy (TiAl6V4) 12743-70-3
Titanium D1JT611TNE
Alkaline Phosphatase EC 3.1.3.1
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97

Informations de copyright

© 2021. The Author(s).

Références

Tissue Eng Part C Methods. 2009 Jun;15(2):115-24
pubmed: 19072196
Biomaterials. 2002 Mar;23(6):1447-54
pubmed: 11829440
Med Sci Monit Basic Res. 2016 Sep 26;22:95-106
pubmed: 27667570
Biomed Mater. 2018 May 15;13(4):045013
pubmed: 29657156
J Biomed Mater Res A. 2015 May;103(5):1677-92
pubmed: 25111154
Stem Cells Int. 2016;2016:6180487
pubmed: 26880976
J Bone Miner Res. 2011 Nov;26(11):2634-46
pubmed: 21735478
J Biomed Mater Res. 1995 Mar;29(3):389-401
pubmed: 7542245
Stem Cell Res. 2018 Jul;30:69-80
pubmed: 29803144
Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:690-701
pubmed: 26652423
J Mech Behav Biomed Mater. 2019 Feb;90:20-29
pubmed: 30342276
Acta Orthop. 2014 Apr;85(2):107-16
pubmed: 24650019
J Biomed Mater Res A. 2008 Mar 15;84(4):1111-9
pubmed: 17685409
Biomaterials. 2001 Jun;22(11):1241-51
pubmed: 11336296
Biomaterials. 1998 Dec;19(23):2219-32
pubmed: 9884063
Med Biol Eng Comput. 2002 May;40(3):311-22
pubmed: 12195978
J Cell Mol Med. 2004 Jul-Sep;8(3):301-16
pubmed: 15491506
Biomaterials. 2006 Mar;27(7):955-63
pubmed: 16115681
Biomaterials. 1998 Jul;19(13):1197-215
pubmed: 9720903
Ann Clin Biochem. 2018 May;55(3):308-327
pubmed: 29368538
J Healthc Eng. 2019 Sep 22;2019:3212594
pubmed: 31662833
Biomaterials. 2008 Sep;29(27):3625-3635
pubmed: 18556060
Mol Cell Endocrinol. 2004 Dec 30;228(1-2):79-102
pubmed: 15541574
BMC Genomics. 2007 Mar 12;8:70
pubmed: 17352823
Nat Rev Mol Cell Biol. 2013 Jun;14(6):329-40
pubmed: 23698583
J Biosci Bioeng. 2008 Jun;105(6):586-94
pubmed: 18640597
PLoS One. 2015 Mar 13;10(3):e0120374
pubmed: 25769043

Auteurs

Kristin S Ødegaard (KS)

Department of Mechanical and Industrial Engineering, Norwegian University of Science and Technology, Trondheim, Norway.

Lingzi Ouyang (L)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Qianli Ma (Q)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Glenn Buene (G)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Di Wan (D)

Department of Mechanical and Industrial Engineering, Norwegian University of Science and Technology, Trondheim, Norway.

Christer W Elverum (CW)

Department of Mechanical and Industrial Engineering, Norwegian University of Science and Technology, Trondheim, Norway.

Jan Torgersen (J)

Department of Mechanical and Industrial Engineering, Norwegian University of Science and Technology, Trondheim, Norway. jan.torgersen@ntnu.no.

Therese Standal (T)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Marita Westhrin (M)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH